Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 19, 2019

Primary Completion Date

October 19, 2019

Study Completion Date

November 19, 2019

Conditions
Cesarean Section Complications
Interventions
DRUG

Dexmedetomidine Injectable Product

Spinal anesthesia and intravenous dexmedetomidine (1μg/kg). The administrated drugs were slowly injected intravenously over 10 minutes then intrathecal block was achieved using 2-2.2 ml of hyperbaric bupivacaine (10 -12.5 mg) introduced at L3/4 or L4/5 interspace.

DRUG

Saline

Spinal anesthesia and intravenous saline. The administrated drugs were slowly injected intravenously over 10 minutes then intrathecal block was achieved using 2-2.2 ml of hyperbaric bupivacaine (10 -12.5 mg) introduced at L3/4 or L4/5 interspace.

Trial Locations (1)

Unknown

Al-Azhar University Faculty of Medicine, Cairo

All Listed Sponsors
lead

Egyptian Biomedical Research Network

NETWORK

NCT04358367 - Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia | Biotech Hunter | Biotech Hunter